Sign In

Sam Cooper

CTO, Co-Founder, Phenomic

Sam Cooper is a dedicated researcher specializing in applying advanced machine-learning techniques to process complex phenotypic data, aiming to pinpoint and market innovative drug targets.

Co-founder of Phenomic AI, Sam leads groundbreaking work utilizing one of the largest single-cell RNA datasets to target solid tumors, particularly focusing on the tumor stroma's unique characteristics in cancer progression.

His pioneering research spotlights an unexplored element of the extracellular matrix that displays promising results across various human tissue samples, potentially revolutionizing treatments for challenging cancer cases.

Sam Cooper holds a PhD from the Department of Computational Medicine at Imperial College, where he collaborated with esteemed professors like Robert Glen and contributed to the Dynamical Cell Systems team at the Institute of Cancer Research under the guidance of Dr. Chris Bakal, leveraging computational tools to address pivotal inquiries in cancer biology.

Sam Cooper
Add to my network

Location

Toronto, Ontario, Canada